Jump Financial
PLXP

Jump Financial’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Jump Financial’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,600
Closed -$75K – 2145
2022
Q1 		$75K Sell
18,600
-15,591
-46% -$85.5K ﹤0.01% 1439
2021
Q4 		$274K Sell
34,191
-209
-0.6% -$2.45K 0.02% 937
2021
Q3 		$664K Buy
+34,400
New +$601K 0.05% 408
2021
Q2 		– Sell
-27,800
Closed -$251K – 1484
2021
Q1 		$251K Buy
+27,800
New +$203K 0.02% 675

Other funds holding PLXP

MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Federation des caisses Desjardins du Quebec
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Jump Financial's PLXP Position: Q2 2022 in Review

Jump Financial sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2022, closing a stake of 18,600 shares — an estimated $75K sold.

Jump Financial first reported a position in PLXP in Q1 2021 and held it in 4 quarters. The position peaked at $664K in Q3 2021. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

  • Jump Financial reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Jump Financial sold 18,600 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $75K.
  • Jump Financial first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Jump Financial's PLx Pharma Inc. Common Stock position peaked at $664K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Jump Financial's 13F filing for Q2 2022, filed 9 Aug 2022.